Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-11-03 Purchase |
2020-11-03 9:36 pm |
Atea Pharmaceuticals Inc. | AVIR | Hack Andrew A. F. Director |
250,000 | $24 | $6,000,000 | 5,615,659 (Indirect) |
View |
| 2020-11-03 Purchase |
2020-11-03 8:09 pm |
Atea Pharmaceuticals Inc. | AVIR | BERGER FRANKLIN M Director |
41,666 | $24 | $999,984 | 820,019 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-11-03 Conversion |
2020-11-03 9:36 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Hack Andrew A. F. Director |
10,731,318 | $0 | 5,615,659 (Indirect) |
View |
| 2020-11-03 Conversion |
2020-11-03 8:09 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Murphy Polly A. Director |
22,590 | $0 | 11,295 (Indirect) |
View |
| 2020-11-03 Conversion |
2020-11-03 8:09 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | BERGER FRANKLIN M Director |
1,519,212 | $0 | 820,019 (Direct) |
View |
| 2020-11-03 Conversion |
2020-11-03 8:08 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Corcoran Andrea See Remarks |
266,008 | $0 | 633,004 (Direct) |
View |
| 2020-11-03 Conversion |
2020-11-03 8:08 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre President, CEO, and Chairman |
750,000 | $0 | 5,925,000 (Indirect) |
View |
| 2020-11-03 Conversion |
2020-11-03 8:05 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Chu Chung K. 10% Owner |
353,724 | $0 | 1,176,862 (Direct) |
View |
| 2020-11-03 Conversion |
2020-11-03 8:04 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer |
82,508 | $0 | 82,508 (Indirect) |
View |
| 2020-10-29 Option Award |
2020-10-30 5:49 pm |
N/A 2030-10-28 |
Atea Pharmaceuticals Inc. | AVIR | Duncan Barbara Gayle Director |
80,000 | $0 | 80,000 (Direct) |
View |
| 2020-10-29 Option Award |
2020-10-30 5:47 pm |
N/A 2030-10-28 |
Atea Pharmaceuticals Inc. | AVIR | BERGER FRANKLIN M Director |
80,000 | $0 | 80,000 (Direct) |
View |
| 2020-10-29 Option Award |
2020-10-30 5:43 pm |
N/A 2030-10-28 |
Atea Pharmaceuticals Inc. | AVIR | Polsky Bruce Director |
80,000 | $0 | 80,000 (Direct) |
View |
| 2020-10-29 Option Award |
2020-10-30 5:41 pm |
N/A 2030-10-28 |
Atea Pharmaceuticals Inc. | AVIR | Lucidi Bruno Director |
80,000 | $0 | 80,000 (Direct) |
View |
| 2020-10-29 Option Award |
2020-10-30 5:40 pm |
N/A 2030-10-28 |
Atea Pharmaceuticals Inc. | AVIR | Foster Wayne See Remarks |
40,000 | $0 | 40,000 (Direct) |
View |
| 2020-10-29 Option Award |
2020-10-30 5:39 pm |
N/A 2030-10-28 |
Atea Pharmaceuticals Inc. | AVIR | Cheng Isaac Director |
80,000 | $0 | 80,000 (Direct) |
View |
| 2020-10-29 Option Award |
2020-10-30 5:18 pm |
N/A 2030-10-28 |
Atea Pharmaceuticals Inc. | AVIR | Hack Andrew A. F. Director |
80,000 | $0 | 80,000 (Direct) |
View |
Ownership |
2020-10-29 8:50 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Vavricka John Chief Commercial Officer |
0 | $0 | 472,508 (Indirect) |
View |
Ownership |
2020-10-29 8:50 pm |
N/A 2029-12-12 |
Atea Pharmaceuticals Inc. | AVIR | Foster Wayne See Remarks |
0 | $0 | 359,732 (Direct) |
View |
Ownership |
2020-10-29 8:50 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Lucidi Bruno Director |
0 | $0 | 175,000 (Direct) |
View |
Ownership |
2020-10-29 8:50 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Rock Springs Capital Management LP Rock Springs Capital Master Fund LP Rock Springs Capital LLC 10% Owner |
0 | $0 | 1,694,419 (Indirect) |
View |
Ownership |
2020-10-29 8:45 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | BERGER FRANKLIN M Director |
0 | $0 | 809,606 (Direct) |
View |
Ownership |
2020-10-29 8:45 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Polsky Bruce Director |
0 | $0 | 175,000 (Direct) |
View |
Ownership |
2020-10-29 8:45 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Murphy Polly A. Director |
0 | $0 | 91,295 (Indirect) |
View |
Ownership |
2020-10-29 8:45 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Sommadossi Jean-Pierre JPM Partners LLC President, CEO, and Chairman 10% Owner |
0 | $0 | 7,110,000 (Indirect) |
View |
Ownership |
2020-10-29 8:45 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Corcoran Andrea See Remarks |
0 | $0 | 1,023,004 (Direct) |
View |
Ownership |
2020-10-29 8:45 pm |
N/A 2030-08-19 |
Atea Pharmaceuticals Inc. | AVIR | Hammond Janet MJ Chief Development Officer |
0 | $0 | 650,000 (Direct) |
View |
Ownership |
2020-10-29 8:45 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Chu Chung K. 10% Owner |
0 | $0 | 1,176,862 (Direct) |
View |
Ownership |
2020-10-29 8:45 pm |
N/A 2030-08-25 |
Atea Pharmaceuticals Inc. | AVIR | Horga Maria Arantxa Acting Chief Medical Officer |
0 | $0 | 350,000 (Direct) |
View |
Ownership |
2020-10-29 8:35 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Hack Andrew A. F. Director |
0 | $0 | 5,365,659 (Indirect) |
View |
Ownership |
2020-10-29 6:42 pm |
N/A N/A |
Atea Pharmaceuticals Inc. | AVIR | Cormorant Asset Management LP Chen Bihua CORMORANT PRIVATE HEALTHCARE FUND I LP Cormorant Private Healthcare Fund II LP 10% Owner |
0 | $0 | 6,411,355 (Indirect) |
View |